Neuro-Oncology Reviews
Volume
25 Number 21
15 November 2023
Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 21, 15 November
Marangon D, Lecca D.
Exosomal
non-coding RNAs in glioma progression: insights into tumor
microenvironment dynamics and therapeutic implications.
Front
Cell Dev Biol. 2023 Nov 1;11:1275755∟.
doi: 10.3389/fcell.2023.1275755∟.
PMID: 38020906∟.
Review. ˍ
Mofatteh M, Mashayekhi MS, Arfaie
S, Wei H, Kazerouni A, Skandalakis GP, Pour-Rashidi A, Baiad A,
Elkaim L, Lam J, Palmisciano P, Su X, Liao X, Das S, Ashkan K,
Cohen-Gadol AA.
Awake
craniotomy during pregnancy: A systematic review of the published
literature.
Neurosurg
Rev. 2023 Nov 1;46(1):290∟.
doi: 10.1007/s10143-023-02187-x∟.
PMID: 37910275∟.
Review. ˍ
Hu M, Liao X, Tao Y, Chen
Y.
Advances
in oncolytic herpes simplex virus and adenovirus therapy for
recurrent glioma.
Front
Immunol. 2023 Nov 2;14:1285113∟.
doi: 10.3389/fimmu.2023.1285113∟.
PMID: 38022620∟.
Review. ˍ
Kutuk T, Atak E, La Rosa A, Kotecha
R, Mehta MP, Chuong MD.
Tumor
treating fields: narrative review of a promising treatment
modality for cancer.
Chin
Clin Oncol. 2023 Nov 2:cco-23-82∟.
doi: 10.21037/cco-23-82∟.
PMID: 37953242∟.
Review. ˍ
Cacciotti C, Wright KD.
Advances
in Treatment of Diffuse Midline Gliomas.
Curr
Neurol Neurosci Rep. 2023 Nov 3∟.
doi: 10.1007/s11910-023-01317-8∟.
PMID: 37921944∟.
Review˰ ˍ
Mastrangelo S.
Special
Issue: Childhood Brain Cancer Treatment.
Cancers
(Basel). 2023 Nov 3;15(21):5278∟.
doi: 10.3390/cancers15215278∟.
PMID: 37958448∟.
Editorial. ˍ
Sugii N, Ninomiya Y, Akimoto Y,
Tsurubuchi T, Ishikawa E.
H3
K27-altered diffuse midline glioma in adults arising from atypical
regions: Two case reports and literature review.
Radiol
Case Rep. 2023 Nov 3;19(1):200-206∟.
doi: 10.1016/j.radcr.2023.10.031∟.
PMID: 38028289∟.
Case report, Review. ˍ
Verma R, Rao L, Kumar H, Bansal N,
Deep A, Parashar J, Yadav M, Mittal V, Kaushik D.
Applications
of Nanomedicine in Brain Tumor Therapy: Nanocarrierbased Drug
Delivery Platforms, CChallenges, and Perspectives.
Recent
Pat Nanotechnol. 2023 Nov 3∟.
doi: 10.2174/0118722105244482231017102857∟.
PMID: 37937554∟.
Review˰ ˍ
*Rangwala BS, Shakil A, Mustafa MS, Rangwala HS, Fatima H, Siddiq
MA.
Losartan and Immune Checkpoint
Inhibitors in Glioblastoma: An Appropriate Substitute for
Steroids.
Ann
Neurosci. 2023 Nov 3;31(3):152-154. doi:
10.1177/09727531231191880. PMID:
39156623. Perspective. ˍ
Dagher SA, Lochner RH, Ozkara BB, Schomer DF, Wintermark M, Fuller
GN, Ucisik FE.
The T2-FLAIR mismatch
sign in oncologic neuroradiology: History, current use, emerging
data, and future directions.
Neuroradiol J. 2023 Nov
4:19714009231212375∟.
doi: 10.1177/19714009231212375∟.
PMID: 37924213∟.
Review. ˍ
Altaf A, Shakir M, Malik MJA, Arif
A, Islam O, Mubarak F, Knopp E, Siddiqui K, Enam
SA.
Intraoperative
use of low-field magnetic resonance imaging for brain tumors: A
systematic review.
Surg
Neurol Int. 2023 Oct 6;14:357∟.
doi: 10.25259/SNI_510_2023∟.
PMID: 37941620∟.
Review. ˍ
Zhao J, Zang F, Huo X, Zheng
S.
Novel
approaches targeting ferroptosis in treatment of glioma.
Front
Neurol. 2023 Nov 6;14:1292160∟.
doi: 10.3389/fneur.2023.1292160∟.
PMID: 38020609∟.
Review. ˍ
Fangusaro J, Jones DT, Packer RJ,
Gutmann DH, Milde T, Witt O, Mueller S, Fisher MJ, Hansford JR,
Tabori U, Hargrave D, Bandopadhayay P.
Pediatric
low-grade glioma: State-of-the-art and ongoing challenges.
Neuro
Oncol. 2023 Nov 7:noad195∟.
doi: 10.1093/neuonc/noad195∟.
PMID: 37944912∟.
Review. ˍ
Ius T, Lombardi G, Baiano C,
Berardinelli J, Romano A, Montemurro N, Cavallo LM, Pasqualetti F,
Feletti A.
Surgical
Management of Adult Brainstem Gliomas: A Systematic Review and
Meta-Analysis.
Curr
Oncol. 2023 Nov 7;30(11):9772-9785∟.
doi: 10.3390/curroncol30110709∟.
PMID: 37999129∟.
Review, Meta-analysis. ˍ
Hasan I, Roy S, Ehexige E, Wu R,
Chen Y, Gao Z, Guo B, Chang C.
A
state-of-the-art liposome technology for glioblastoma
treatment.
Nanoscale.
2023 Nov 8∟.
doi: 10.1039/d3nr04241c∟.
PMID: 37937394∟.
Review˰ ˍ
Kienzler JC, Becher B.
Immunity
in malignant brain tumors - Tumor entities, role of immunotherapy,
and specific contribution of myeloid cells to the brain tumor
microenvironment.
Eur
J Immunol. 2023 Nov 8:e2250257∟.
doi: 10.1002/eji.202250257∟.
PMID: 37940552∟.
Review. ˍ
Agarwal A, Bathla G, Soni N, Desai
A, Ajmera P, Rao D, Gupta V, Vibhute P.
Newly
Recognized Genetic Tumor Syndromes of the CNS in the 5th WHO
Classification: Imaging Overview with Genetic Updates.
AJNR
Am J Neuroradiol. 2023 Nov 9∟.
doi: 10.3174/ajnr.A8039∟.
PMID: 37945522∟.
Review. ˍ
Bosio A, Caffo M, Dipasquale A,
Krengli M, Simonelli M, Lombardi G.
Editorial:
Novel diagnostic and therapeutic strategies in the management of
cerebral gliomas, Volume II.
Front
Oncol. 2023 Nov 9;13:1306332∟.
doi: 10.3389/fonc.2023.1306332∟.
PMID: 38023137∟.
Editorial. ˍ
Foster JB, Koptyra MP, Bagley
SJ.
Recent
Developments in Blood Biomarkers in Neuro-oncology.
Curr
Neurol Neurosci Rep. 2023 Nov 9∟.
doi: 10.1007/s11910-023-01321-y∟.
PMID: 37943477∟.
Review˰ ˍ
Jackson K, Packer RJ.
Recent
Advances in Pediatric Medulloblastoma.
Curr
Neurol Neurosci Rep. 2023 Nov 9∟.
doi: 10.1007/s11910-023-01316-9∟.
PMID: 37943476∟.
Review. ˍ
Soffietti R.
Editorial:
Advances in basic science and technology are bringing new flavor
in neuro-oncology.
Curr
Opin Neurol. 2023 Nov 9;36(6):541-543∟.
doi: 10.1097/WCO.0000000000001215∟.
PMID: 37973022∟.
Editorial˰ ˍ
Colamaria A, Leone A, Fochi NP, Di
Napoli V, Giordano G, Landriscina M, Patel K, Carbone F.
Tumor
treating fields for the treatment of glioblastoma: Current
understanding and future perspectives.
Surg
Neurol Int. 2023 Nov 10;14:394∟.
doi: 10.25259/SNI_674_2023∟.
PMID: 38053701∟.
Review. ˍ
Yoda RA, Cimino PJ.
Classification
and Grading of Central Nervous System Tumors According to the
World Health Organization 5th Edition.
Semin
Neurol. 2023 Nov 10∟.
doi: 10.1055/s-0043-1776793∟.
PMID: 37949117∟.
Review˰ ˍ
Rousseau J, Bennett J, Lim-Fat
MJ.
Brain
Tumors in Adolescents and Young Adults: A Review.
Semin
Neurol. 2023 Nov 10∟.
doi: 10.1055/s-0043-1776775∟.
PMID: 37949116∟.
Review˰ ˍ
Matsunaga K, Fukami S, Nakajima N,
Ichimasu N, Kohno M.
Patient
with Diffuse Midline Glioma, H3 K27-altered, Carrying an FGFR1
Mutation
Who Experienced Thalamic Hemorrhage: A Case Report and Literature
Review.
NMC Case
Rep J. 2023 Nov 11;10:309-314∟.
doi: 10.2176/jns-nmc.2023-0035∟.
PMID: 38076395∟.
Case report, Review. ˍ
Pour ME, Moghadam SG, Shirkhani P,
Sahebkar A, Mosaffa F.
Therapeutic
cell-based vaccines for glioblastoma multiforme.
Med
Oncol. 2023 Nov 12;40(12):354∟.
doi: 10.1007/s12032-023-02220-5∟.
PMID: 37952224∟.
Review˰ ˍ
Gan HK, Parakh S, Osellame LD, Cher
L, Uccellini A, Hafeez U, Menon S, Scott AM.
Antibody
drug conjugates for glioblastoma: current progress towards
clinical use.
Expert
Opin Biol Ther. 2023 Nov 13:1-14∟.
doi: 10.1080/14712598.2023.2282729∟.
PMID: 37955063∟.
Review˰ ˍ
Ramapriyan R, Sun J, Curry A,
Richardson LG, Ramesh T, Gaffey MA, Gedeon PC, Gerstner ER, Curry
WT, Choi BD.
The
Role of Antibody-Based Therapies in Neuro-Oncology.
Antibodies
(Basel). 2023 Nov 13;12(4):74∟.
doi: 10.3390/antib12040074∟.
PMID: 37987252∟.
Review. ˍ
Kilic Durankus N, Samanci Y,
Düzkalir AH, Peker S.
Unveiling
the Efficacy of Gamma Knife Radiosurgery for Tectal Plate
Gliomas.
Neurosurgery.
2023 Nov 13∟.
doi: 10.1227/neu.0000000000002754∟.
PMID: 37955438∟.
Observational study, Review˰ ˍ
Campion A, Iv M.
Brain
Tumor Imaging: Review of Conventional and Advanced
Techniques.
Semin
Neurol. 2023 Nov 14∟.
doi: 10.1055/s-0043-1776765∟.
PMID: 37963581∟.
Review˰ ˍ
Hardigan AA, Jackson JD, Patel
AP.
Surgical
Management and Advances in the Treatment of Glioma.
Semin
Neurol. 2023 Nov 14∟.
doi: 10.1055/s-0043-1776766∟.
PMID: 37963582∟.
Review˰ ˍ
Long S, Yan Y, Xu H, Wang L, Jiang
J, Xu Z, Liu R, Zhou Q, Huang X, Chen J, Li Z, Wei W, Li
X.
Insights
into the regulatory role of RNA methylation modifications in
glioma.
J Transl
Med. 2023 Nov 14;21(1):810∟.
doi: 10.1186/s12967-023-04653-y∟.
PMID: 37964279∟.
Review. ˍ
Xiang X, Ji Z, Jin J.
Brachytherapy
is an effective and safe salvage option for re-irradiation in
recurrent glioblastoma (rGBM): a systematic review.
Radiother
Oncol. 2023 Nov 14:110012∟.
doi: 10.1016/j.radonc.2023.110012∟.
PMID: 37972737∟.
Review˰ ˍ
Folkins S, Miller A, Nash CM.
Risk
of venous thromboembolism in pregnant patients with active
malignancy: A systematic review and meta-analysis.
Acta
Obstet Gynecol Scand. 2023 Nov 15∟.
doi: 10.1111/aogs.14712∟.
PMID: 37968882∟.
Review. ˍ
McGrady ME, Willard VW, Williams
AM, Brinkman TM.
Psychological
Outcomes in Adolescent and Young Adult Cancer Survivors.
J
Clin Oncol. 2023 Nov 15:JCO2301465∟.
doi: 10.1200/JCO.23.01465∟.
PMID: 37967297∟.
Review˰ ˍ
Yang X, Man D, Zhao P, Li
X.
Quantitative
study of bioinformatics analysis on glioma: a bibliometric
analysis.
Front
Oncol. 2023 Nov 15;13:1222797∟.
doi: 10.3389/fonc.2023.1222797∟.
PMID: 38045000∟.
Bibliometric analysis. ˍ